Abstract
Novel antibiotics didemnins A, B and C (didemnins), and nordidemnins A, B and C (nordidemnins) which can be obtained from a marine organism. These antibiotics are active against a variety of DNA and RNA viruses; thus, they can be used in various environments to control or eradicate these viruses. Further, these antibiotics can be used to treat animals and humans hosting acute myelocytic leukemia and acute lymphocytic leukemia.
Original language | English (US) |
---|---|
U.S. patent number | 4950649 |
Filing date | 12/23/87 |
State | Published - Aug 21 1990 |